Acceptability and Feasibility of a Mindfulness-Based Intervention for Pain Catastrophizing among Persons with Sickle Cell Disease |
| |
| Affiliation: | 1. Duke University School of Nursing, Durham, North Carolina;2. BioVirtua, San Francisco, California;3. Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina;1. School of Nursing & Health Studies, University of Washington Bothell, Bothell, Washington;2. College of Nursing, University of South Carolina, Columbia, South Carolina;3. School of Medicine, University of Washington, Seattle, Washington;4. College of Nursing, University of Illinois at Chicago, Chicago, Illinois;1. VA HSR&D Center for Care Delivery and Outcomes Research, Minneapolis VA Health Care System, Minneapolis, Minnesota;2. Department of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota;3. Department of Medicine, VA New York Harbor Healthcare System, New York, New York;4. Department of Population Health, New York University School of Medicine, New York, New York;1. Emory University School of Medicine, Department of Pediatrics, United States;2. Children’s Healthcare of Atlanta, Aflac Cancer and Blood Disorders Center, United States;3. Georgia State University, Department of Psychology, United States;1. Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, United States;2. Hematology/Oncology, Department of Medicine, University of California, Irvine and Southern California Institute for Research and Education, VA Medical Center, Long Beach, CA, United States;1. Pediatric Palliative Care Program, Children''s National Medical Center, District of Columbia, Washington, United States;2. Division of Hematology, Center for Cancer and Blood Disorders, Children’s National Medical Center, District of Columbia, Washington, United States;3. Division of Anesthesiology, Pain, and Perioperative Medicine, Children''s National Medical Center, District of Columbia, Washington, United States;4. Division of Biostatistics and Study Methodology, Children''s National Medical Center;5. Department of Pediatrics, George Washington University School of Medicine and Health Sciences, District of Columbia, United States |
| |
| Abstract: | BackgroundFew investigators have developed and tested nonpharmacological interventions for helping persons with sickle cell disease (SCD) manage persistent pain.AimsThe purpose of this pilot study was to examine the feasibility and acceptability of a mindfulness-based intervention (MBI) in adults with SCD and chronic pain and to gather preliminary data on its efficacy.DesignData on feasibility and acceptability, including recruitment, retention, and attendance rates, were collected during a single-site, randomized control trial. Participants were randomly assigned to either a 6-session group telephonic MBI or a wait-listed control. Pain catastrophizing was assessed at baseline and at weeks 1, 3, and 6.SettingOutpatient, comprehensive, interdisciplinary sickle cell disease center in the Southeast.Participants/SubjectsAdults at least 18 years of age with a self-reported diagnosis of sickle cell disease who self-identified as having chronic, non-cancer pain that persisted on most days for at least 6 months and adversely affected function and/or well-being.MethodsSeventy-eight adults were recruited; 18 (23%) declined to participate; 60 were randomly assigned to either the MBI (N = 40) or control (N = 20). Of those, 14 (35%) from the MBI and 12 (60%) from the control group withdrew immediately after random allocation, resulting in 34 evaluable cases (MBI: N = 26; control: N = 8).ResultsAmong the 26 assigned to MBI, the median number of sessions attended per person was 4; 7 (27%) attended all six sessions. Qualitative findings indicated that MBI participants viewed the program as acceptable and liked the telephonic format, community, and content. Reductions in pain catastrophizing outcomes were identified after intervention.ConclusionsAn MBI is feasible and acceptable for persons with SCD experiencing chronic pain. A larger randomized controlled trial to establish MBI efficacy on pain and related outcomes for SCD will provide nonpharmacologic, behavioral pain management options for nurses and other clinicians caring for persons with SCD and chronic pain. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
